前收市價 | 0.0500 |
開市 | 0.0500 |
買盤 | 0.0100 |
賣出價 | 0.5500 |
拍板 | 2.50 |
到期日 | 2024-09-20 |
今日波幅 | 0.0500 - 0.0500 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 871 |
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Whitefort Capital wants biopharmaceutical firm Arbutus to stop issuing stock. Shah Capital ended a proxy campaign against biotech Novavax.
A bird flu outbreak could spur demand for vaccines from these key players, but is it likely?